BOSENTIME 62.5

Description

BOSENTIME 62.5 is a prescription medicine that contains Bosentan 62.5 mg, a dual endothelin receptor antagonist widely used to treat pulmonary arterial hypertension (PAH). This condition causes high blood pressure in the arteries of the lungs, leading to shortness of breath, fatigue, and reduced physical capacity. By blocking the action of endothelin—a substance that causes blood vessels to constrict—Bosentan helps relax and widen the blood vessels, improving blood flow and reducing the workload on the heart. BOSENTIME 62.5, manufactured by Steris Healthcare, is known for its quality, efficacy, and reliability in the management of PAH. This product is gaining recognition for its clinical effectiveness in improving exercise ability and slowing the progression of PAH. BOSENTIME 62.5 plays a crucial role in enhancing patient quality of life under the guidance of a healthcare provider. What is BOSENTIME 62.5? BOSENTIME 62.5 is a tablet formulation containing Bosentan 62.5 mg, an endothelin receptor antagonist used primarily for treating pulmonary arterial hypertension (PAH). It helps reduce elevated blood pressure in the lungs and improves exercise capacity and symptoms in patients suffering from PAH. Uses of BOSENTIME 62.5 Treatment of Pulmonary Arterial Hypertension (PAH) in adults and children over 12 years of age Improves exercise capacity and delays clinical worsening in PAH May also be used in systemic scleroderma patients with ongoing digital ulcers (off-label use as per physician advice) Side Effects of BOSENTIME 62.5 While BOSENTIME 62.5 is effective in treating PAH, it may cause some side effects in certain individuals, including: Headache Flushing Nasal congestion Edema (swelling of legs, ankles, or feet) Abnormal liver function tests Low red blood cell count (anemia) Respiratory tract infections Patients must undergo regular liver function and hemoglobin monitoring while on this medication. Precautions Before Using BOSENTIME 62.5 Liver Monitoring: Bosentan may cause liver damage. Liver function tests should be done regularly. Pregnancy and Breastfeeding: This drug can harm an unborn baby. Effective contraception is mandatory during treatment and one month after stopping. Birth Control: Bosentan can reduce the effectiveness of hormonal contraceptives. Use two reliable forms of contraception. Kidney Function: Use with caution in patients with renal impairment. Driving and Machinery Use: Dizziness or low blood pressure may affect your ability to drive or operate machinery. Drug Interactions: What Drugs Interact with BOSENTIME 62.5? BOSENTIME 62.5 may interact with several medications, altering their effects or increasing side effects. Notable drug interactions include: Cyclosporine A – Contraindicated due to increased bosentan levels Glyburide – Risk of liver enzyme elevation Hormonal contraceptives – Effectiveness reduced Warfarin – Monitor INR closely Rifampicin, Ketoconazole, Fluconazole – May alter bosentan levels Sildenafil or Tadalafil – May increase risk of low blood pressure when used together Always inform your doctor about all the medications, supplements, and herbal products you are taking before starting BOSENTIME 62.5. Conclusion BOSENTIME 62.5 (Bosentan 62.5 mg) by Steris Healthcare is a trusted solution in the management of pulmonary arterial hypertension. With its vasodilating properties, it significantly improves exercise capacity and symptom control in PAH patients. However, careful monitoring for liver function and potential drug interactions is essential. Consult your healthcare provider for the correct dosage and follow-up care to ensure safety and effectiveness. Choose BOSENTIME 62.5 for advanced and reliable management of PAH—where quality meets patient care.